Mindoo

AI agents for hospital workflows

Mindoo develops configurable AI agents for hospital intake, patient access, clinical documentation, and follow-up workflows. Their platform includes voice-first AI agents for hospital intake and patient communication.

Shareable draft

Check out Mindoo on @MedStartr Today Mindoo develops configurable AI agents for hospital intake, patient access, clinical documentation, and follow-up workflows. Their platform includes voice-first AI agents for hospital intake and patient communication. #ClinicalDocumentation #MedMo #MedStartrVentures

https://www.medstartr.ai/s/wYbSdsQTThc

Get Involved in Mindoo

How We Help

Problem Statement

Hospitals face significant challenges in managing complex and time-consuming workflows related to patient intake, access, clinical documentation, and follow-up, leading to inefficiencies and potential for errors.

Core Technology

Configurable AI agent platform with four core agents: Max (Intake Agent), Sara (Reception Agent), Lisa (Follow-up Agent), and Jimmy (Scribe Agent). The platform also leverages voice-first AI agents.

Key Differentiators

Supports custom agent configuration tailored to specific workflows; GDPR-native platform; Compliant with MDR and EU AI Act regulations; Integrates with modern EHR systems

Clinical Focus

hospital intake; patient access; clinical documentation; follow-up workflows

Company Info

Business Model: B2B SaaS
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now

Technologies

EHR IntegrationSpeech & Voice AIAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

Deployed in Belgian and German hospital EDs; Pre-Visit Agent operational; all pilot sites advancing to full implementation

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Mindoo?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.